Cadrenal TherapeuticsCVKD
13F holders, Q1 2025 (March 31)3holders +2
2new positions
0sold out
$17.56avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Cadrenal Therapeutics Inc. (CVKD) in their 13F filings, up 2 from Q4 2024. 2 opened new positions and 0 sold out. The largest holders were Farther Finance Advisors, LLC ($437), Carolina Wealth Advisors, LLC ($353) and Caldwell Sutter Capital, Inc. ($88).
- Company
- Cadrenal Therapeutics Inc.
- CUSIP
- 127636108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $441 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 25 shares bought, net +25 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Farther Finance Advisors, LLC | 0.00% | No change | 25 | $437 |
| Carolina Wealth Advisors, LLC | 0.00% | New | 20 | $353 |
| Caldwell Sutter Capital, Inc. | 0.00% | New | 5 | $88 |
"% of holder's portfolio" is CVKD's weight in each manager's 13F, not the share of Cadrenal Therapeutics Inc. the manager owns.